3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
57
Recurrence
7
Neoplasms, Plasma Cell
5
Neoplasms
4
Smoldering Multiple Myeloma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Paraproteinemias
1
Immunoglobulin Light-chain Amyloidosis
1
Glioblastoma
1
Disease
1
Chromosome 17 deletion
1
Interventions
pomalidomide
1
daratumumab
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Chromosome 17 deletion
×
daratumumab
×
Clear all
NCT04124497
2025-08-08
DPd
Fondazione EMN Italy Onlus
Phase 2
Active not recruiting
45 enrolled